The global Intraosseous Infusion Devices market was valued at 3340.43 Million USD in 2021 and will grow with a CAGR of 5.84% from 2021 to 2027, based on Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Intraosseous infusion (IO) is the process of injecting directly into the marrow of a bone. This provides a non-collapsible entry point into the systemic venous system. This technique is used to provide fluids and medication when intravenous access is not available or not feasible. Intraosseous infusions allow for the administered medications and fluids to go directly into the vascular system.The automatic intraosseous devices allow quick and safe access to the patient`s vascular system for fluid and drug administration. There are several FDA approved IO devices: The BIG Bone Injection Gun and The NIO New Intra Osseous device are automatic intra-osseous infusion device used by military and civilian healthcare systems.

By Market Verdors:

By Types:

By Applications:

Key Indicators Analysed

Key Reasons to Purchase

LEAVE A REPLY

Please enter your comment!
Please enter your name here